help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albrandt, K.
Right arrow Articles by Beaumont, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albrandt, K.
Right arrow Articles by Beaumont, K.

Endocrinology, Vol 136, 5377-5384, Copyright © 1995 by Endocrine Society


ARTICLES

Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene

K Albrandt, EM Brady, CX Moore, E Mull, ME Sierzega and K Beaumont
Department of Pharmacology, Amylin Pharmaceuticals, Inc., San Diego, California 92121-3027, USA.

We have cloned and expressed two isoforms of the human calcitonin (hCT) receptor. Primers designed from the published sequence of a CT receptor cloned from an ovarian small cell carcinoma line were used for the polymerase chain reaction amplification of related products from human breast carcinoma MCF-7 cells. Two complementary DNAs were isolated. One clone lacks a 16-amino acid insert in the first intracellular loop and is virtually identical to the receptor recently cloned from the T47D human breast carcinoma cell line. The second clone is another splice variant lacking both the 16-amino acid insert in the first intracellular domain as well as the first 47 amino acids of the amino- terminus extracellular domain. COS-7 cells transfected with either receptor isoform bound [125I]salmon CT with high affinity and responded to hCT with increases in cAMP. Tissue distribution studies revealed the truncated extracellular domain 1 isoform transcripts in human skeletal muscle, kidney, brain, and lung. Analysis of a hCT receptor genomic clone demonstrated an exon/intron organization similar to that of the porcine CT receptor gene, except for a distinct exon coding for the alternatively spliced insert in the first intracellular domain.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Pham, M. Dong, J. D. Wade, L. J. Miller, C. J. Morton, H.-l. Ng, M. W. Parker, and P. M. Sexton
Insights into Interactions between the {alpha}-Helical Region of the Salmon Calcitonin Antagonists and the Human Calcitonin Receptor using Photoaffinity Labeling
J. Biol. Chem., August 5, 2005; 280(31): 28610 - 28622.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Yaoi, M. Suzuki, H. Tomura, Y. Sasayama, S. Kikuyama, and S. Tanaka
Molecular Cloning of Otoconin-22 Complementary Deoxyribonucleic Acid in the Bullfrog Endolymphatic Sac: Effect of Calcitonin on Otoconin-22 Messenger Ribonucleic Acid Levels
Endocrinology, August 1, 2003; 144(8): 3287 - 3296.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord
International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. A. Tverberg, M. F. Gustafson, T. L. Scott, I. V. Arzumanova, E. R. Provost, A. W. Yan, and S. A. Rawie
Induction of Calcitonin and Calcitonin Receptor Expression in Rat Mammary Tissue during Pregnancy
Endocrinology, October 1, 2000; 141(10): 3696 - 3702.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Christopoulos, K. J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N. J. Fraser, M. J. Main, S. M. Foord, and P. M. Sexton
Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product
Mol. Pharmacol., July 1, 1999; 56(1): 235 - 242.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. Inoue, C. Shih, D. L. Galson, S. R. Goldring, W. C. Horne, and R. Baron
Calcitonin-Dependent Down-Regulation of the Mouse C1a Calcitonin Receptor in Cells of the Osteoclast Lineage Involves a Transcriptional Mechanism
Endocrinology, March 1, 1999; 140(3): 1060 - 1068.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. R. Nussenzveig, M. D. F. C. Matos, and C. N. Thaw
Human calcitonin receptor is directly targeted to and retained in the basolateral surface of MDCK cells
Am J Physiol Cell Physiol, November 1, 1998; 275(5): C1264 - C1276.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W.-J. Chen, S. Armour, J. Way, G. Chen, C. Watson, P. Irving, J. Cobb, S. Kadwell, K. Beaumont, T. Rimele, et al.
Expression Cloning and Receptor Pharmacology of Human Calcitonin Receptors from MCF-7 Cells and Their Relationship to Amylin Receptors
Mol. Pharmacol., December 1, 1997; 52(6): 1164 - 1175.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. P. Cohen, C. N. Thaw, A. Varma, M. C. Gershengorn, and D. R. Nussenzveig
Human Calcitonin Receptors Exhibit Agonist-Independent (Constitutive) Signaling Activity
Endocrinology, April 1, 1997; 138(4): 1400 - 1405.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Roux, F. Pichaud, J. Quinn, A. Lalande, C. Morieux, A. Jullienne, and M.-C. de Vernejoul
Effects of Prostaglandins on Human Hematopoietic Osteoclast Precursors
Endocrinology, April 1, 1997; 138(4): 1476 - 1482.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Quiza, M. Dowton, K. J. Perry, and P. M. Sexton
Electrophoretic Mobility and Glycosylation Characteristics of Heterogeneously Expressed Calcitonin Receptors
Endocrinology, February 1, 1997; 138(2): 530 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Shyu, D. Inoue, R. Baron, and W. C. Horne
The Deletion of 14Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C
J. Biol. Chem., December 6, 1996; 271(49): 31127 - 31134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bergwitz, T. J. Gardella, M. R. Flannery, J. T. Potts Jr., H. M. Kronenberg, S. R. Goldring, and H. Juppner
Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin. EVIDENCE FOR A COMMON PATTERN OF LIGAND-RECEPTOR INTERACTION
J. Biol. Chem., October 25, 1996; 271(43): 26469 - 26472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Anusaksathien, C. Laplace, X. Li, Y. Ren, L. Peng, S. R. Goldring, and D. L. Galson
Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor Gene
J. Biol. Chem., June 15, 2001; 276(25): 22663 - 22674.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society